These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12729848)

  • 1. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
    Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
    Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A
    J Am Geriatr Soc; 2003 Jan; 51(1):123-6. PubMed ID: 12534856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systolic and diastolic heart failure in the elderly.
    Aronow WS
    J Am Med Dir Assoc; 2006 Jan; 7(1):29-36. PubMed ID: 16413432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of heart failure--an overview.
    Erdmann E
    Basic Res Cardiol; 2000; 95 Suppl 1():I3-7. PubMed ID: 11192349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of heart failure caused by systolic dysfunction.
    Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM
    Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT; Wagoner LE
    Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical advances in the treatment of congestive heart failure.
    Armstrong PW; Moe GW
    Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present and future pharmacotherapy for heart failure.
    Doggrell SA; Brown L
    Expert Opin Pharmacother; 2002 Jul; 3(7):915-30. PubMed ID: 12083991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological therapy of heart failure with reduced ejection fraction].
    Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
    Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.